Leukemia, Myelodysplasia, Transplantation
News
Extended virus shedding after COVID-19 in some patients with cancer
Some patients, including stem cell transplant and CAR T recipients, may require extended periods of isolation.
Conference Coverage
Black race linked to poorer survival in AML
Conference Coverage
Fixed duration ibrutinib/venetoclax appears feasible for some CLL/SLL patients
Conference Coverage
In MDS, transplant ups survival in elderly and may be reimbursed
Conference Coverage
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest
Cancer patients treated with immune checkpoint inhibitors are not significantly more likely to develop or die from COVID-19, two studies suggest...
News
Pigment traits, sun sensitivity associated with risk of non-Hodgkin lymphomas and chronic lymphocytic leukemia
The presence of “many or very many nevi [moles]” was particularly associated with the risk of CLL.
Article
Using telehealth to deliver palliative care to cancer patients
Dr. Alan Lyss discusses the use of telehealth for palliative cancer care, including results from the REACH PC trial.
News
Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patients
News
Beat AML: Precision medicine strategy feasible, superior to SOC for AML
"The study is changing significantly the way we look at treating patients with AML, showing that precision medicine ... can improve short- and...
Conference Coverage
Novel agents hold promise for frontline AML treatment
